<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang H</submitter><funding>Group Research Scheme</funding><funding>Collaborative Research Fund of University Grants Committee</funding><funding>National Natural Science Foundation of China</funding><funding>Health and Medical Research Fund</funding><pagination>667</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11223378</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The available evidence presented inconsistencies and inconclusive findings regarding the associations between co-existing asthma and mortality among COVID-19 patients. The objective of the current study is to investigate the relationship between asthma and severe outcomes after SARS-CoV-2 Omicron infection in an infection-naïve population.&lt;h4>Methods&lt;/h4>A retrospective cohort study using propensity score matching was conducted. The COVID-19 patients requiring hospitalisation in Hong Kong from January 1, 2022, to November 13, 2022, an Omicron-predominated period, were identified. Severe clinical outcomes were defined as ICU admission and inpatient death after the first positive PCR results as well as a composite outcome of both.&lt;h4>Results&lt;/h4>Of the 74,396 hospitalised </pubmed_abstract><journal>BMC infectious diseases</journal><pubmed_title>Association between asthma and COVID-19 severity during Omicron epidemic: a retrospective cohort study using real-world data.</pubmed_title><pmcid>PMC11223378</pmcid><funding_grant_id>71974165</funding_grant_id><funding_grant_id>C4139-20G</funding_grant_id><funding_grant_id>COVID190105</funding_grant_id><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Guo Z</pubmed_authors><pubmed_authors>Chan KCC</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Yam CHK</pubmed_authors><pubmed_authors>Chong KC</pubmed_authors><pubmed_authors>Li K</pubmed_authors><pubmed_authors>Wei Y</pubmed_authors><pubmed_authors>Hung CT</pubmed_authors><pubmed_authors>Yeoh EK</pubmed_authors><pubmed_authors>Chow TY</pubmed_authors><pubmed_authors>Zhao S</pubmed_authors><pubmed_authors>Jiang X</pubmed_authors><pubmed_authors>Chan RWY</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Leung EYM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association between asthma and COVID-19 severity during Omicron epidemic: a retrospective cohort study using real-world data.</name><description>&lt;h4>Background&lt;/h4>The available evidence presented inconsistencies and inconclusive findings regarding the associations between co-existing asthma and mortality among COVID-19 patients. The objective of the current study is to investigate the relationship between asthma and severe outcomes after SARS-CoV-2 Omicron infection in an infection-naïve population.&lt;h4>Methods&lt;/h4>A retrospective cohort study using propensity score matching was conducted. The COVID-19 patients requiring hospitalisation in Hong Kong from January 1, 2022, to November 13, 2022, an Omicron-predominated period, were identified. Severe clinical outcomes were defined as ICU admission and inpatient death after the first positive PCR results as well as a composite outcome of both.&lt;h4>Results&lt;/h4>Of the 74,396 hospitalised </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-04-04T12:55:04.151Z</modification><creation>2025-04-04T12:55:04.151Z</creation></dates><accession>S-EPMC11223378</accession><cross_references><pubmed>38961350</pubmed><doi>10.1186/s12879-024-09520-9</doi></cross_references></HashMap>